Alik Farber, MD
Professor
Boston University School of Medicine
Dept of Surgery
Vascular and Endovascular Surgery

MD, Harvard Medical School




Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.

Section Chief
Boston University School of Medicine
Surgery
Vascular and Endovascular Surgery

Professor
Boston University School of Medicine
Radiology
Vascular & Interventional



A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols
05/01/2012 - 12/31/2015 (PI)
Grifols Inc


A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm^2 to <= 36 cm^2
10/15/2013 - 08/30/2015 (PI)
HealthPoint Limited


A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer
05/01/2012 - 04/30/2015 (PI)
HealthPoint Limited


Observational Study of Tissue Plasminogen Activator Used for Catheter Directed Thrombolysis in Patients with Acute Lower Extremety Native Artery or Bypass Graft Occlusion
01/27/2014 - 01/26/2015 (PI)
Grifols Inc


A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
05/01/2012 - 04/30/2014 (PI)
HealthPoint Limited


Vital Access Venous Window Needle Guide for salvage of AV Fistulae (SAVE) Trial
08/15/2012 - 08/14/2013 (PI)
Vital Access Corp


IN-BALANCE VLU (Inflammation, Bacteria, and Angiogenesis effects in launching venous leg ulcer healing: a clinical evaluation)
08/01/2012 - 07/31/2013 (PI)
Celleration, Inc.


A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals


A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals


A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
08/01/2009 - 12/31/2011 (PI)
HealthPoint Limited


Showing 10 of 16 results. Show All Results

Dose-response relationship study of S42909 on leg ulcer healing after oral repeated administration..
08/06/2018 - 08/05/2021 (PI)
Ilkos Therapeutic Inc

A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external suppo
11/01/2017 - 11/01/2020 (PI)
Laminate Medical Technologies Inc.

RANGER
06/19/2017 - 06/19/2020 (PI)
Boston Scientific Corporation

BEST-CLI Trial-CCC-Lead
09/17/2013 - 03/31/2019 (PI)
Brigham & Women's NIH-NHLBI
5U01HL107352-05

Randomized Trial Comparing a Dual Action Pneumatic Compression System against Multi-Layer Bandagi…
06/15/2016 - 06/14/2018 (PI)
ACTitouch Medical

Open versus Endovascular Popliteal Artery Aneurysm (OVER-PAR) Repair Trial
11/01/2013 - 06/30/2017 (PI)
New England Society for Vascular Surgery

A Phase-3 Study of Curexcell
12/04/2014 - 12/31/2016 (PI)
Macro Cure Ltd.

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients with…
12/31/2014 - 12/31/2015 (PI)
Tactile Medical

Vascular Physician Offer and Report (VAPOR) Trial
12/01/2014 - 12/31/2015 (PI)
Dartmouth-Hitchcock Medical Center

TOPVENT
02/01/2006 - 01/31/2007 (PI)
GlaxoSmithKline



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Levin SR, Farber A, Cheng TW, Jones DW, Rybin D, Kalish JA, Bennett KM, Arinze N, Siracuse JJ. Most patients experiencing 30-day postoperative stroke after carotid endarterectomy will initially experience disability. J Vasc Surg. 2019 May 05.View Related Profiles. PMID: 31068266.
     
  2. Powell R, Menard M, Farber A, Rosenfield K, Goodney P, Gray B, Lookstein R, Pena C, Schermerhorn M. Comparison of specialties participating in the BEST-CLI trial to specialists treating peripheral arterial disease nationally. J Vasc Surg. 2019 May; 69(5):1505-1509. PMID: 31010516.
     
  3. Siracuse JJ, Cheng TW, Farber A, James T, Zuo Y, Kalish JA, Jones DW, Kalesan B. Vascular repair after firearm injury is associated with increased morbidity and mortality. J Vasc Surg. 2019 May; 69(5):1524-1531.e1.View Related Profiles. PMID: 31010517.
     
  4. Cheng TW, Farber A, Rajani RR, Jones DW, Flynn D, Rybin D, Doros G, Kalish JA, Meltzer AJ, Siracuse JJ. National criteria for academic appointment in vascular surgery. J Vasc Surg. 2019 May; 69(5):1559-1565.View Related Profiles. PMID: 31010519.
     
  5. Siracuse JJ, Cheng TW, Arinze NV, Levin SR, Jones DW, Malas MB, Kalish JA, Rybin D, Farber A. Snuffbox arteriovenous fistulas have similar outcomes and patency as wrist arteriovenous fistulas. J Vasc Surg. 2019 Mar 02.View Related Profiles. PMID: 30837175.
     
  6. Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vasc Med. 2019 Jun; 24(3):251-260.View Related Profiles. PMID: 30823859.
     
  7. Farber A, Rosenfield K, Siami FS, Strong M, Menard M. The BEST-CLI trial is nearing the finish line and promises to be worth the wait. J Vasc Surg. 2019 02; 69(2):470-481.e2. PMID: 30683195.
     
  8. Cheng TW, Farber A, Eslami MH, Kalish JA, Jones DW, Rybin D, Siracuse JJ. Removal of infected arteriovenous grafts is morbid and many patients do not receive a new access within 1 year. J Vasc Surg. 2018 Dec 24.View Related Profiles. PMID: 30591289.
     
  9. Roberts L, Farber A, Jones DW, Woo K, Eslami MH, Simons J, Malas M, Tan TW, Rybin D, Siracuse JJ. Tapered arteriovenous grafts do not provide significant advantage over nontapered grafts in upper extremity dialysis access. J Vasc Surg. 2019 May; 69(5):1552-1558.View Related Profiles. PMID: 30583896.
     
  10. Siracuse JJ, Farber A, Cheng TW, Raulli SJ, Jones DW, Kalish JA, Smeds MR, Rybin D, Schermerhorn ML. Common femoral artery antegrade and retrograde approaches have similar access site complications. J Vasc Surg. 2019 Apr; 69(4):1160-1166.e2.View Related Profiles. PMID: 30527937.
     
Showing 10 of 232 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 231 publications over 21 distinct years, with a maximum of 41 publications in 2016

YearPublications
19921
19931
19992
20011
20022
20033
20044
20051
20073
20082
20096
20104
201112
20129
201319
201415
201521
201641
201738
201839
20197

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
Contact for Mentoring:

75 E. Newton St Collamore Building
Boston MA 02118
Google Map


Farber's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department